Impact of skin cancer screening and secondary prevention campaigns on skin cancer incidence and mortality: A systematic review - 18/04/17
, Annika Waldmann, PhD a, Nora Eisemann, PhD a, Alexander Katalinic, MD a, bAbstract |
Background |
Benefits of skin cancer screening remain controversial.
Objective |
We sought to update evidence on the impact of skin cancer screening and secondary prevention campaigns on skin cancer incidence, mortality, stage-specific incidence, and interval cancers after negative screening.
Methods |
We searched MEDLINE and EMBASE for studies published in English or German between January 1, 2005, and February 4, 2015. Two reviewers independently performed study selection, data extraction, and critical appraisal. Results were described in a narrative synthesis.
Results |
Of 2066 records identified in databases and 10 records found by manual search, we included 15 articles. Overall, evidence suggests that with implementation of skin cancer screening, incidence of in situ and invasive skin cancer increased; increasing rates of thin and decreasing rates of thick melanoma were observed. After cessation of screening, invasive melanoma incidence decreased. A significant melanoma mortality reduction was shown in a German study; 2 other studies observed fewer deaths than expected. No study on interval cancers was identified.
Limitations |
Publication bias cannot be ruled out. Most studies are limited because of their ecological design.
Conclusion |
Large ecological studies, a cohort study, a case-control study, and a survey indicate benefits of skin cancer screening, but the evidence level is very low.
Le texte complet de cet article est disponible en PDF.Key words : incidence, interval cancers, melanoma, mortality, screening, secondary prevention, skin cancer, stage-specific incidence, systematic review, thickness
Abbreviations used : EASR, SCREEN, USPSTF, WASR
Plan
| Funding sources: None. |
|
| Disclosure: Drs Waldmann, Eisemann, and Katalinic are authors of several of the included publications. Ms Brunssen has no conflicts of interest to declare. |
|
| Supplemental Table I, Supplemental Table II, Supplemental Table III, Supplemental Table IV, Supplemental Table V, Supplemental Table VI are available at www.jaad.org. |
|
| PROSPERO registration number: CRD42014013400. |
|
| Presented as a poster at the annual conference of the German Network for Evidence-based Medicine (DNEbM) in Berlin, Germany, on March 13, 2015; an oral presentation at the annual conference of the German Society for Epidemiology in Potsdam, Germany, on October 1, 2015; and an oral presentation at the annual conference of DNEbM in Cologne, Germany, on March 4, 2016. |
Vol 76 - N° 1
P. 129 - janvier 2017 Retour au numéro
Article précédent
- Variation among pathologists' treatment suggestions for melanocytic lesions: A survey of pathologists
- Kachiu C. Lee, Sue Peacock, Martin A. Weinstock, Ge Alice Zhao, Stevan R. Knezevich, David E. Elder, Raymond L. Barnhill, Michael W. Piepkorn, Lisa M. Reisch, Patricia A. Carney, Tracy Onega, Jason P. Lott, Joann G. Elmore
- The effect of climate change on skin disease in North America
- Benjamin H. Kaffenberger, David Shetlar, Scott A. Norton, Misha Rosenbach
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?